PGXL announces new contractual agreement with GH

NewsGuard 100/100 Score

PGXL, a Louisville-based molecular diagnostics laboratory, announced a new contractual agreement with Generation Health, Inc. (GH). The agreement makes PGXL a preferred genetic testing lab for GH. The lab will provide molecular diagnostic tests for GH, which will help physicians make therapeutic decisions and facilitate what has come to be known as "personalized medicine."

"The affiliation with Generation Health takes our company, and the reality of personalized medicine, to a whole new level," says Dr. Roland Valdes, Jr., co-founder and Chairman of PGXL. "This is going to improve the standard of care for millions of patients."

GH and PGXL will begin partnering in July 2010 to facilitate pharmacogenetic testing and diagnostic services to healthcare providers for patient care. In January, 2011, GH plans to expand the program, offering managed diagnostic testing to all GH clients.

"PGXL was the first lab to be CLIA-certified exclusively for pharmacogenetics testing and we're pleased that PGXL is part of our Best Test™ laboratory network," said GH Chief Executive Officer Rick Schatzberg.  "We believe PGXL's long-standing clinical expertise and their commitment to provide caregivers the most accurate and timely pharmacogenetic tests possible strengthens our ability to provide our clients with the best genetic laboratory network available."

Pharmacogenetics – the science of using genetic information to guide medical treatment – promises to revolutionize the way medicine is practiced.  

"How a particular drug affects a particular patient is determined, in large measure, by that patient's genetics," says Dr. Mark Linder, Executive Vice President and co-founder of PGXL. "Armed with that information, physicians can choose the best treatment path for an individual patient. It eliminates a lot of trial and error, along with the expense and suffering that go along with that."

SOURCE PGXL Laboratories, LLC


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Enhancer-gene mapping with SCENT method offers insights into disease mechanisms